Camurus AB (publ) (0RD1.L)
SEK 572.18
(1.54%)
SEK 572.18
(1.54%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 414.81 Million SEK | 33.46% |
| 2022 | 310.81 Million SEK | 33.4% |
| 2021 | 232.98 Million SEK | 18.47% |
| 2020 | 196.65 Million SEK | 40.06% |
| 2019 | 140.41 Million SEK | 24.92% |
| 2018 | 112.4 Million SEK | 23.61% |
| 2017 | 90.93 Million SEK | 20.67% |
| 2016 | 75.35 Million SEK | -57.13% |
| 2015 | 175.79 Million SEK | 108.75% |
| 2014 | 84.21 Million SEK | 36.69% |
| 2013 | 61.6 Million SEK | 258.3% |
| 2012 | 17.19 Million SEK | -77.46% |
| 2011 | 76.3 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 503.72 Million SEK | 21.36% |
| 2024 Q1 | 415.06 Million SEK | 0.06% |
| 2023 Q3 | 353.35 Million SEK | -9.79% |
| 2023 Q4 | 414.81 Million SEK | 17.4% |
| 2023 FY | 414.81 Million SEK | 33.46% |
| 2023 Q1 | 288.58 Million SEK | -7.15% |
| 2023 Q2 | 391.67 Million SEK | 35.72% |
| 2022 Q1 | 238.9 Million SEK | 2.54% |
| 2022 Q3 | 265.1 Million SEK | 8.04% |
| 2022 FY | 310.81 Million SEK | 33.4% |
| 2022 Q4 | 310.81 Million SEK | 17.24% |
| 2022 Q2 | 245.37 Million SEK | 2.71% |
| 2021 Q4 | 232.98 Million SEK | 6.61% |
| 2021 Q2 | 226.05 Million SEK | 11.89% |
| 2021 Q3 | 218.53 Million SEK | -3.32% |
| 2021 FY | 232.98 Million SEK | 18.47% |
| 2021 Q1 | 202.02 Million SEK | 2.73% |
| 2020 Q3 | 165.96 Million SEK | -4.49% |
| 2020 FY | 196.65 Million SEK | 40.06% |
| 2020 Q4 | 196.65 Million SEK | 18.49% |
| 2020 Q2 | 173.76 Million SEK | 8.72% |
| 2020 Q1 | 159.82 Million SEK | 13.83% |
| 2019 Q3 | 147.47 Million SEK | 1.93% |
| 2019 Q2 | 144.68 Million SEK | 1.75% |
| 2019 Q1 | 142.19 Million SEK | 26.51% |
| 2019 FY | 140.41 Million SEK | 24.92% |
| 2019 Q4 | 140.41 Million SEK | -4.79% |
| 2018 Q3 | 101.9 Million SEK | -4.89% |
| 2018 Q2 | 107.14 Million SEK | 23.16% |
| 2018 Q1 | 86.99 Million SEK | -4.33% |
| 2018 FY | 112.4 Million SEK | 23.61% |
| 2018 Q4 | 112.4 Million SEK | 10.3% |
| 2017 FY | 90.93 Million SEK | 20.67% |
| 2017 Q1 | 73.42 Million SEK | -2.57% |
| 2017 Q4 | 90.93 Million SEK | 8.81% |
| 2017 Q3 | 83.57 Million SEK | 2.49% |
| 2017 Q2 | 81.54 Million SEK | 11.06% |
| 2016 Q3 | 57.46 Million SEK | 1.84% |
| 2016 FY | 75.35 Million SEK | -57.13% |
| 2016 Q4 | 75.35 Million SEK | 31.15% |
| 2016 Q2 | 56.42 Million SEK | 2.51% |
| 2016 Q1 | 55.04 Million SEK | -68.69% |
| 2015 Q4 | 175.79 Million SEK | 64.05% |
| 2015 Q3 | 107.15 Million SEK | 0.0% |
| 2015 FY | 175.79 Million SEK | 108.75% |
| 2015 Q1 | - SEK | -100.0% |
| 2014 Q4 | 84.21 Million SEK | 0.0% |
| 2014 FY | 84.21 Million SEK | 36.69% |
| 2013 FY | 61.6 Million SEK | 258.3% |
| 2012 FY | 17.19 Million SEK | -77.46% |
| 2011 FY | 76.3 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AddLife AB (publ) | 7.78 Billion SEK | 94.672% |
| Bonesupport Holding AB (publ) | 143.63 Million SEK | -188.793% |